elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37693410-3EC1F355-99A6-46FE-931F-77DCF83BB629
Q37693410-3EC1F355-99A6-46FE-931F-77DCF83BB629
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37693410-3EC1F355-99A6-46FE-931F-77DCF83BB629
Identification of recurrent BRCA1 mutation and its clinical relevance in Chinese Triple-negative breast cancer cohort.
P2860
Q37693410-3EC1F355-99A6-46FE-931F-77DCF83BB629
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37693410-3EC1F355-99A6-46FE-931F-77DCF83BB629
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
278912d68118359cffc04a40535f1b35a1b6efea
P2860
Abstract S3-01: The TNT trial: A randomized phase III trial of carboplatin (C) compared with docetaxel (D) for patients with metastatic or recurrent locally advanced triple negative or BRCA1/2 breast cancer (CRUK/07/012)